Molecular Imaging Nuclear Medicine (MINM) plays a central role in Precision Medicine and personalized management of oncological and non-oncological disorders. With recent developments in hybrid imaging such as whole-body PET/CT and PET/MR along with new tracers for Theranostics, MINM is a leading specialty in clinical care, translational research, and drug designing.
It is important that the MINM specialists and scientists share their knowledge and experience so that the techniques are widely available and appropriately applied. With this objective MINM service at HMC organized the first MINM Conference in March 2022. The hybrid meeting was attended by more than 400 MINM practitioners from 17 countries. Thirty-four presentations by the experts, technical workshops, and vendor exhibitions provided an opportunity for the attendee to know the recent happening.
To view the detailed conference program, please visit the official conference website at:
https://www.hamad.qa/EN/All-Events/2QMINM/Programs/Pages/Parallel-program.aspx
View Conference Flyer, Speakers & Venue please click below link
https://acrobat.adobe.com/id/urn:aaid:sc:AP:d4e98801-2aa1-4a01-bd9e-387276e5a7ef
For Registration click here
https://www.hamad.qa/EN/All-Events/2QMINM/Programs/Pages/Parallel-program.aspx
View Conference Flyer, Speakers & Venue please click below link
https://acrobat.adobe.com/id/urn:aaid:sc:AP:d4e98801-2aa1-4a01-bd9e-387276e5a7ef
For Registration click here